Getinge AB (publ) (GNGBF)
USD 15.68
(0.0%)
USD 15.68
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 3.9 Billion SEK | -22.42% |
| 2022 | 5.03 Billion SEK | 43.95% |
| 2021 | 3.49 Billion SEK | -54.53% |
| 2020 | 7.68 Billion SEK | 8.76% |
| 2019 | 7.06 Billion SEK | -4.2% |
| 2018 | 7.37 Billion SEK | 48.69% |
| 2017 | 4.96 Billion SEK | -68.82% |
| 2016 | 15.91 Billion SEK | -0.57% |
| 2015 | 16 Billion SEK | 11.32% |
| 2014 | 14.37 Billion SEK | 5.99% |
| 2013 | 13.56 Billion SEK | 3.06% |
| 2012 | 13.16 Billion SEK | -12.95% |
| 2011 | 15.12 Billion SEK | 32.51% |
| 2010 | 11.41 Billion SEK | -28.85% |
| 2009 | 16.03 Billion SEK | 21.95% |
| 2008 | 13.15 Billion SEK | 43.78% |
| 2007 | 9.14 Billion SEK | 108.62% |
| 2006 | 4.38 Billion SEK | 6.83% |
| 2005 | 4.1 Billion SEK | 11.09% |
| 2004 | 3.69 Billion SEK | 13.83% |
| 2003 | 3.24 Billion SEK | 34.36% |
| 2002 | 2.41 Billion SEK | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 2.86 Billion SEK | -56.26% |
| 2024 Q3 | 5.91 Billion SEK | 106.35% |
| 2024 Q1 | 8.33 Billion SEK | 67.95% |
| 2023 Q4 | 3.9 Billion SEK | -42.72% |
| 2023 Q1 | 5.81 Billion SEK | 15.6% |
| 2023 Q2 | 6.89 Billion SEK | 18.52% |
| 2023 Q3 | 6.81 Billion SEK | -1.15% |
| 2023 FY | 3.9 Billion SEK | -22.42% |
| 2022 Q4 | 5.03 Billion SEK | -8.51% |
| 2022 Q2 | 5 Billion SEK | 32.4% |
| 2022 Q1 | 3.77 Billion SEK | 8.1% |
| 2022 Q3 | 5.49 Billion SEK | 9.94% |
| 2022 FY | 5.03 Billion SEK | 43.95% |
| 2021 Q2 | 4.99 Billion SEK | -15.16% |
| 2021 FY | 3.49 Billion SEK | -54.53% |
| 2021 Q4 | 3.49 Billion SEK | -20.11% |
| 2021 Q3 | 4.37 Billion SEK | -12.38% |
| 2021 Q1 | 5.88 Billion SEK | -23.44% |
| 2020 Q4 | 7.68 Billion SEK | -36.13% |
| 2020 FY | 7.68 Billion SEK | 8.76% |
| 2020 Q1 | 11.11 Billion SEK | 57.22% |
| 2020 Q2 | 13.28 Billion SEK | 19.53% |
| 2020 Q3 | 12.03 Billion SEK | -9.38% |
| 2019 Q3 | 11.63 Billion SEK | -0.54% |
| 2019 Q2 | 11.69 Billion SEK | 0.03% |
| 2019 FY | 7.06 Billion SEK | -4.2% |
| 2019 Q1 | 11.69 Billion SEK | 58.46% |
| 2019 Q4 | 7.06 Billion SEK | -39.24% |
| 2018 Q2 | 11.56 Billion SEK | 5.63% |
| 2018 Q4 | 7.37 Billion SEK | -31.25% |
| 2018 FY | 7.37 Billion SEK | 48.69% |
| 2018 Q3 | 10.73 Billion SEK | -7.18% |
| 2018 Q1 | 10.94 Billion SEK | 120.6% |
| 2017 FY | 4.96 Billion SEK | -68.82% |
| 2017 Q1 | 21.72 Billion SEK | 36.53% |
| 2017 Q3 | 16.14 Billion SEK | -22.73% |
| 2017 Q2 | 20.89 Billion SEK | -3.82% |
| 2017 Q4 | 4.96 Billion SEK | -69.27% |
| 2016 Q4 | 15.91 Billion SEK | -27.43% |
| 2016 FY | 15.91 Billion SEK | -0.57% |
| 2016 Q3 | 21.92 Billion SEK | -0.64% |
| 2016 Q2 | 22.07 Billion SEK | 1.57% |
| 2016 Q1 | 21.73 Billion SEK | 35.76% |
| 2015 Q4 | 16 Billion SEK | -26.91% |
| 2015 FY | 16 Billion SEK | 11.32% |
| 2015 Q3 | 21.89 Billion SEK | 1.41% |
| 2015 Q2 | 21.59 Billion SEK | -3.07% |
| 2015 Q1 | 22.27 Billion SEK | 54.94% |
| 2014 Q2 | 19.09 Billion SEK | 17.83% |
| 2014 Q3 | 19.99 Billion SEK | 4.73% |
| 2014 Q4 | 14.37 Billion SEK | -28.1% |
| 2014 Q1 | 16.2 Billion SEK | 19.45% |
| 2014 FY | 14.37 Billion SEK | 5.99% |
| 2013 Q2 | 17.19 Billion SEK | 0.0% |
| 2013 Q1 | - SEK | -100.0% |
| 2013 Q4 | 13.56 Billion SEK | -16.39% |
| 2013 FY | 13.56 Billion SEK | 3.06% |
| 2013 Q3 | 16.22 Billion SEK | -5.63% |
| 2012 Q2 | - SEK | 0.0% |
| 2012 Q4 | 13.16 Billion SEK | 0.0% |
| 2012 FY | 13.16 Billion SEK | -12.95% |
| 2012 Q1 | - SEK | -100.0% |
| 2012 Q3 | - SEK | 0.0% |
| 2011 FY | 15.12 Billion SEK | 32.51% |
| 2011 Q4 | 15.12 Billion SEK | 0.0% |
| 2011 Q3 | - SEK | 0.0% |
| 2011 Q2 | - SEK | 0.0% |
| 2011 Q1 | - SEK | -100.0% |
| 2010 Q1 | - SEK | -100.0% |
| 2010 Q2 | - SEK | 0.0% |
| 2010 Q4 | 11.41 Billion SEK | 0.0% |
| 2010 Q3 | - SEK | 0.0% |
| 2010 FY | 11.41 Billion SEK | -28.85% |
| 2009 Q4 | 16.03 Billion SEK | 0.0% |
| 2009 FY | 16.03 Billion SEK | 21.95% |
| 2008 FY | 13.15 Billion SEK | 43.78% |
| 2007 FY | 9.14 Billion SEK | 108.62% |
| 2006 FY | 4.38 Billion SEK | 6.83% |
| 2005 FY | 4.1 Billion SEK | 11.09% |
| 2004 FY | 3.69 Billion SEK | 13.83% |
| 2003 FY | 3.24 Billion SEK | 34.36% |
| 2002 FY | 2.41 Billion SEK | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| AVITA Medical, Inc. | 449.48 Thousand USD | -868230.949% |
| Manhattan Scientifics, Inc. | - USD | -Infinity% |
| Össur hf. | 311.8 Million USD | -1151.756% |
| QHSLab, Inc. | - USD | -Infinity% |
| Wellstar International, Inc. | 18.86 Million USD | -20592.861% |
| Össur hf. | 311.8 Million USD | -1151.756% |
| CVR Medical Corp. | - USD | -Infinity% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| Escalon Medical Corp. | 279.4 Thousand USD | -1396801.977% |
| Aurora Spine Corporation | 1.59 Million USD | -245092.117% |
| BrainsWay Ltd. | 239 Thousand USD | -1632954.393% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| BioElectronics Corporation | 12.52 Million USD | -31050.159% |
| Hamilton Thorne Ltd. | 16.7 Million USD | -23263.071% |
| Vivos Inc. | - USD | -Infinity% |
| Kelyniam Global, Inc. | 217.61 Thousand USD | -1793467.421% |
| REMSleep Holdings, Inc. | 43.67 Thousand USD | -8936157.899% |
| Zecotek Photonics Inc. | - USD | -Infinity% |
| Avitar, Inc. | 3.89 Million USD | -100068.05% |
| Nanomix Corporation | 10.11 Million USD | -38499.763% |
| EKF Diagnostics Holdings plc | 618 Thousand USD | -631453.398% |
| Theraclion SA | 1.95 Million EUR | -199978.329% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Positron Corporation | - USD | -Infinity% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 150 Thousand USD | -2601900.0% |
| Lombard Medical, Inc. | 28.02 Million USD | -13826.851% |
| ALR Technologies Inc. | - USD | -Infinity% |
| Stratec SE | 89.25 Million USD | -4272.829% |
| Vycor Medical, Inc. | 243.28 Thousand USD | -1604178.075% |
| Heart Tronics, Inc. | - USD | -Infinity% |
| MicroPort Scientific Corporation | 814.21 Million USD | -379.359% |
| VMS Rehab Systems, Inc. | 106.45 USD | -3666509998.638% |
| NewCardio, Inc. | - USD | -Infinity% |
| Guided Therapeutics, Inc. | 511 Thousand USD | -763696.477% |
| Ingen Technologies, Inc. | 532.27 Thousand USD | -733166.2% |
| Odyssey Group International, Inc. | - USD | -Infinity% |
| CYduct Diagnostics, Inc. | 590 Thousand USD | -661425.424% |
| Wellness Center USA, Inc. | 304.6 Thousand USD | -1281252.594% |
| SANUWAVE Health, Inc. | 492 Thousand USD | -793192.683% |
| IR-Med Inc. | 161 Thousand USD | -2424123.602% |
| Perimeter Medical Imaging AI, Inc. | 142.32 Thousand USD | -2742138.054% |
| Polarean Imaging plc | 74.84 Thousand USD | -5214607.533% |
| United American Healthcare Corporation | - USD | -Infinity% |
| ECGI Holdings, Inc. | 804 Thousand USD | -485347.761% |
| Nu-Med Plus, Inc. | - USD | -Infinity% |
| Capital Group Holdings, Inc. | - USD | -Infinity% |
| ADM Tronics Unlimited, Inc. | 322.4 Thousand USD | -1210500.431% |
| Medical Supply International USA, Inc. | 116.05 Thousand USD | -3362989.596% |
| Urologix, Inc. | 4.58 Million USD | -85006.847% |
| Rapid Therapeutic Science Laboratories, Inc. | 430.23 Thousand USD | -907078.635% |
| Nexeon MedSystems Inc. | 2.78 Million USD | -139976.782% |
| SS Innovations International, Inc. | 1.91 Million USD | -204199.342% |
| Qualis Innovations, Inc. | - USD | -Infinity% |
| Smith & Nephew plc | 2.17 Billion USD | -79.702% |
| NIOX Group Plc | 500 Thousand USD | -780500.0% |
| Fuse Medical, Inc. | 200 Thousand USD | -1951400.0% |
| Broncus Holding Corporation | 1.22 Million USD | -318772.549% |
| Brain Scientific Inc. | 7378.00 USD | -52900415.045% |
| Pressure BioSciences, Inc. | 161.86 Thousand USD | -2411183.547% |
| Health Logic Interactive Inc. | - USD | -Infinity% |